These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8546397)

  • 1. Direct gene transfer for treatment of human cancer.
    Nabel GJ; Yang ZY; Nabel EG; Bishop K; Marquet M; Felgner PL; Gordon D; Chang AE
    Ann N Y Acad Sci; 1995 Nov; 772():227-31. PubMed ID: 8546397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions.
    Vogelzang NJ; Lestingi TM; Sudakoff G; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1357-70. PubMed ID: 7893807
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer.
    Rubin J; Charboneau JW; Reading C; Kovach JS
    Hum Gene Ther; 1994 Nov; 5(11):1385-99. PubMed ID: 7893809
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
    Nabel GJ; Nabel EG; Yang ZY; Fox BA; Plautz GE; Gao X; Huang L; Shu S; Gordon D; Chang AE
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11307-11. PubMed ID: 8248244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes.
    Nabel GJ; Gordon D; Bishop DK; Nickoloff BJ; Yang ZY; Aruga A; Cameron MJ; Nabel EG; Chang AE
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15388-93. PubMed ID: 8986821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
    Hersh EM; Akporiaye E; Harris D; Stopeck AT; Unger EC; Warneke JA; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1371-84. PubMed ID: 7893808
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Aug; 3(4):399-410. PubMed ID: 1525212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic therapy targeting metastatic melanoma: allovectin-7.
    Chowdhery R; Gonzalez R
    Immunotherapy; 2011 Jan; 3(1):17-21. PubMed ID: 21174553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule.
    DeBruyne L
    Cancer Immunol Immunother; 1996 Nov; 43(3):180-9. PubMed ID: 9001572
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of malignancy by in vivo gene transfer into tumors.
    Plautz GE; Yang ZY; Wu BY; Gao X; Huang L; Nabel GJ
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4645-9. PubMed ID: 8506311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
    Rini BI; Selk LM; Vogelzang NJ
    Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis.
    Nabel EG; Plautz G; Nabel GJ
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5157-61. PubMed ID: 1594626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
    [No Abstract]   [Full Text] [Related]  

  • 16. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically modified tumour vaccines--where we are today.
    Nawrocki S; Mackiewicz A
    Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
    Imro MA; Dellabona P; Manici S; Heltai S; Consogno G; Bellone M; Rugarli C; Protti MP
    Hum Gene Ther; 1998 Jun; 9(9):1335-44. PubMed ID: 9650618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.